The crucial role of PDK4 as inhibitor of PDC activity renders it important as a target gene in many cancers and metabolic disorders (Yamane et al, 2014; Zhang et al, 2014; Jeoung, 2015). This evidence concerns the gene PDK4 and Other metabolic disease.